Yapar, SenemBolat, Nurullah2025-05-292025-05-2920251738-1088https://doi.org/10.9758/cpn.24.1211https://hdl.handle.net/20.500.12428/29993This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Mirtazapine is an antidepressant approved by the FDA whose mechanism of action involves antagonism of alpha-2, H1, 5-HT2A, 5-HT2C, and 5-HT3 receptors. Tics are sudden, rapid, purposeless, recurrent, non-rhythmic motor movements or vocalizations. There have been previous case reports of various medications causing tics. In this article, we report tic symptoms that we thought developed in association with mirtazapine treatment. Copyright© 2025, Korean College of Neuropsychopharmacology.eninfo:eu-repo/semantics/openAccessAdolescentMirtazapinePost-traumatic stress disorderTicsArticle23231932210.9758/cpn.24.12112-s2.0-105003462939PMID: 40223266Q2